MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma

CardioVascular and Interventional Radiology

Volumn 33, Issue 3, 2010, Pages 532-540

  Kloeckner, Roman ^a   Otto, Gerd ^a   Biesterfeld, Stefan ^a   Oberholzer, Katja ^a   Dueber, Christoph ^a   Pitton, Michael B ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Computed tomography; DC Bead; Hepatocellular carcinoma; Lipiodol; Magnetic resonance imaging; Transarterial chemoembolization

Indexed keywords

DOXORUBICIN; GADOLINIUM; IODINATED POPPYSEED OIL; MICROSPHERE; PENTETIC ACID;

ADULT; AGED; ARTICLE; ARTIFACT; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CLINICAL DECISION MAKING; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMULSION; FEMALE; FOLLOW UP; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MALE; MINIMAL RESIDUAL DISEASE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TUMOR BIOPSY; TUMOR DIAGNOSIS; TUMOR NECROSIS;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ARTIFACTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; DOXORUBICIN; EMULSIONS; FEMALE; GADOLINIUM DTPA; HUMANS; IODIZED OIL; IOPAMIDOL; LINEAR MODELS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; NECROSIS; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77953134572     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-009-9728-y     Document Type: Article

References (27)

1. Parkin DM, Bray F, Ferlay J et al (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153-156
2. Liu Q, Song Y, Zhou Y et al (2006) A useful agent for chemoprevention of hepatocellular carcinoma? Cancer Biol Ther 5:1674-1676
3. Lodato F, Mazzella G, Festi D et al (2006) Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations. World J Gastroenterol 12:7239-7249
4. Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329-338
5. Bruix J, Llovet JM (2002) Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35:519-524
6. Llovet JM, Fuster J, Bruix J (2004) Barcelona-Clínic Liver Cancer Group. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 10:115-120
7. Cillo U, Bassanello M, Vitale A et al (2004) The critical issue of hepatocellular carcinoma prognostic classification: Which is the best tool available? J Hepatol 40:124-131
8. Cillo U, Vitale A, Grigoletto F et al (2006) Prospective validation of the Barcelona Clinic Liver Cancer staging system. J Hepatol 44:723-731
9. De Giorgio M, Fagiuoli S (2007) Management of hepatocellular carcinoma. Dig Dis 25:279-281
10. Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429-442
11. Satake M, Uchida H, Arai Y et al (2008) Transcatheter arterial chemoembolization (TACE) with lipiodol to treat hepatocellular carcinoma: survey results from the TACE study group of Japan. Cardiovasc Interv Radiol 31:756-761
12. Hihara T, Araki T, Kachi et al (1992) Dense parenchymal accumulation of Lipiodol after transarterial chemoembolization. Radiat Med 10:79-81
13. Takayama T, Makuuchi M, Hirohashi S et al (1990) Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 336:1150-1153
14. Bruix J, Sherman M, Llovet JM et al (2001) EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421-430
15. Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92:205-216 (Pubitemid 30099779)
16. Padhani AR, Ollivier L (2001) The RECIST criteria: implications for diagnostic radiologists. Br J Radiol 74:983-986
17. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208-1236
18. Herber S, Biesterfeld S, Franz U et al (2008) Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome. Cardiovasc Interv Radiol 31:768-777
19. Castrucci M, Sironi S, De Cobelli F et al (1996) Plain and gadolinium-DTPA-enhanced MR imaging of hepatocellular carcinoma treated with transarterial chemoembolization. Abdom Imaging 21:488-494
20. Semelka RC, Worawattanakul S, Mauro MA et al (1998) Malignant hepatic tumors: changes on MRI after hepatic arterial chemoembolization-preliminary findings. J Magn Reson Imaging 8:48-56
21. Kubota K, Hisa N, Nishikawa T et al (2001) Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI. Abdom Imaging 26:184-190
22. De Santis M, Alborino S, Tartoni PL et al (1997) Effects of lipiodol retention on MRI signal intensity from hepatocellular carcinoma and surrounding liver treated by chemoembolization. Eur Radiol 7:10-16
23. Marelli L, Stigliano R, Triantos C et al (2007) Transarterial therapy for hepatocellular carcinoma: Which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Interv Radiol 30:6-25
24. Lewis AL, Gonzalez MV, Lloyd AW et al (2006) DC Bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 17:335-342
25. Johnson PJ, Kalayci C, Dobbs N et al (1991) Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodol. J Hepatol 13:120-127
26. Sultana S, Awai K, Nakayama Y et al (2007) Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector CT scanner to time arterial phase imaging. Radiology 243:140-147
27. Alba E, Valls C, Dominguez J et al (2008) Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma on the waiting list for orthotopic liver transplantation. AJR Am J Roentgenol 190:1341-1348